Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | BRD6340 | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |
mRNA | tanespimycin:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | pifithrin-mu | CTRPv2 | pan-cancer | AAC | 0.015 | 0.7 |
mRNA | RAF265 | CCLE | pan-cancer | AAC | -0.019 | 0.7 |
mRNA | procarbazine | CTRPv2 | pan-cancer | AAC | -0.017 | 0.7 |
mRNA | lapatinib | GDSC1000 | pan-cancer | AAC | 0.021 | 0.7 |
mRNA | JNK Inhibitor VIII | GDSC1000 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | foretinib | CTRPv2 | pan-cancer | AAC | 0.015 | 0.7 |
mRNA | FQI-2 | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | MK-2206 | GDSC1000 | pan-cancer | AAC | 0.014 | 0.7 |